Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reginald V Fant

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Drugs|May 20, 2008
Novel pharmacological approaches for treating tobacco dependence and withdrawal: current statusAugust R Buchhalter, Reginald V Fant, Jack E Henningfield
Psychopharmacology|December 24, 2017
The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and researchJack E Henningfield, Reginald V Fant, Daniel W Wang
Handbook of Experimental Pharmacology|February 3, 2009
Pharmacotherapy for tobacco dependenceReginald V Fant, August R Buchhalter, Albert C Buchman, et al.
Pharmacology, Biochemistry, and Behavior|May 17, 2005
Placebo cigarettes in a spaced smoking paradigmNicole C Eid, Reginald V Fant, Eric T Moolchan, et al.
Brain and Cognition|October 24, 2003
EEG effects of conventional and denicotinized cigarettes in a spaced smoking paradigmWallace B Pickworth, Elizabeth D O'Hare, Reginald V Fant, et al.
CA: a Cancer Journal for Clinicians|September 17, 2005
Pharmacotherapy for nicotine dependenceJack E Henningfield, Reginald V Fant, August R Buchhalter, et al.
The Primary Care Companion for CNS Disorders|April 3, 2020
Assessment of Amphetamine Withdrawal Symptoms of Lisdexamfetamine Dimesylate Treatment for Adults With Binge-Eating DisorderBrigitte Robertson, James Wu, Reginald V Fant, et al.
Expert Opinion on Drug Delivery|November 22, 2005
Nicotine delivery systemsSaul Shiffman, Reginald V Fant, August R Buchhalter, et al.
Pharmacology, Biochemistry, and Behavior|August 15, 2002
Flavor improvement does not increase abuse liability of nicotine chewing gumElisabeth J Houtsmuller, Reginald V Fant, Thomas E Eissenberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2017
Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With DiarrheaReginald V Fant, Jack E Henningfield, Brooks D Cash, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Drugs|May 20, 2008
Novel pharmacological approaches for treating tobacco dependence and withdrawal: current statusAugust R Buchhalter, Reginald V Fant, Jack E Henningfield
Psychopharmacology|December 24, 2017
The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and researchJack E Henningfield, Reginald V Fant, Daniel W Wang
Handbook of Experimental Pharmacology|February 3, 2009
Pharmacotherapy for tobacco dependenceReginald V Fant, August R Buchhalter, Albert C Buchman, et al.
Pharmacology, Biochemistry, and Behavior|May 17, 2005
Placebo cigarettes in a spaced smoking paradigmNicole C Eid, Reginald V Fant, Eric T Moolchan, et al.
Brain and Cognition|October 24, 2003
EEG effects of conventional and denicotinized cigarettes in a spaced smoking paradigmWallace B Pickworth, Elizabeth D O'Hare, Reginald V Fant, et al.
CA: a Cancer Journal for Clinicians|September 17, 2005
Pharmacotherapy for nicotine dependenceJack E Henningfield, Reginald V Fant, August R Buchhalter, et al.
The Primary Care Companion for CNS Disorders|April 3, 2020
Assessment of Amphetamine Withdrawal Symptoms of Lisdexamfetamine Dimesylate Treatment for Adults With Binge-Eating DisorderBrigitte Robertson, James Wu, Reginald V Fant, et al.
Expert Opinion on Drug Delivery|November 22, 2005
Nicotine delivery systemsSaul Shiffman, Reginald V Fant, August R Buchhalter, et al.
Pharmacology, Biochemistry, and Behavior|August 15, 2002
Flavor improvement does not increase abuse liability of nicotine chewing gumElisabeth J Houtsmuller, Reginald V Fant, Thomas E Eissenberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2017
Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With DiarrheaReginald V Fant, Jack E Henningfield, Brooks D Cash, et al.
Pageof 2